Evaluation of the Long-Term Cost-Effectiveness of the Dexcom G6 Continuous Glucose Monitor versus Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in Canada

Evaluation of the Long-Term Cost-Effectiveness of the Dexcom G6 Continuous Glucose Monitor versus Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in Canada

Stephane Roze,1 John J Isitt,1 Jayne Smith-Palmer,2 Peter Lynch3 1Vyoo Agency, Paris, France; 2Ossian Health Economics and Communications, Basel, Switzerland; 3Dexcom, San Diego, CA, USACorrespondence: Jayne Smith-PalmerOssian Health Economics and Communications GmbH, Bäumleingasse 20, Basel, 4051,...

Full description

Bibliographic Details
Main Authors: Roze S, Isitt JJ, Smith-Palmer J, Lynch P
Format: Article
Language:English
Published: Dove Medical Press 2021-08-01
Series:ClinicoEconomics and Outcomes Research
Subjects:
type 1 diabetes
canada
real-time continuous glucose monitoring
cost-effectiveness
Online Access:https://www.dovepress.com/evaluation-of-the-long-term-cost-effectiveness-of-the-dexcom-g6-contin-peer-reviewed-fulltext-article-CEOR

Internet

https://www.dovepress.com/evaluation-of-the-long-term-cost-effectiveness-of-the-dexcom-g6-contin-peer-reviewed-fulltext-article-CEOR

Similar Items